Human Genome Epidemiology Literature Finder
Rare Diseases
|
Records 1 - 23 (of 23 Records) |
| Query Trace: Nodular Melanoma[original query] |
|---|
| BRAF and NRAS mutations are frequent in nodular melanoma but are not associated with tumor cell proliferation or patient survival. The Journal of investigative dermatology 2005 Aug 125 (2): 312-7. Akslen Lars A, Angelini Sabrina, Straume Oddbjørn, Bachmann Ingeborg M, Molven Anders, Hemminki Kari, Kumar Raj |
| FGFR4 Arg388 allele correlates with tumour thickness and FGFR4 protein expression with survival of melanoma patients. British journal of cancer 2006 Jun 94 (12): 1879-86. Streit S, Mestel D S, Schmidt M, Ullrich A, Berking |
| Significance of glutathione S-transferases M1, T1 and P1 polymorphisms in Swedish melanoma patients. Oncology reports 2007 Apr 17 (4): 859-64. Bu H, Rosdahl I, Holmdahl-Källen K, Sun X-F, Zhang |
| Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis. The British journal of dermatology 2011 Apr 164 (4): 776-84. Lee J-H, Choi J-W, Kim Y |
| Polymorphisms in nevus-associated genes MTAP, PLA2G6, and IRF4 and the risk of invasive cutaneous melanoma. Twin research and human genetics : the official journal of the International Society for Twin Studies 2011 Oct 14 (5): 422-32. Kvaskoff Marina, Whiteman David C, Zhao Zhen Z, Montgomery Grant W, Martin Nicholas G, Hayward Nicholas K, Duffy David |
| Inflammasome polymorphisms confer susceptibility to sporadic malignant melanoma. Pigment cell & melanoma research 2012 Jul 25 (4): 506-13. Verma Deepti, Bivik Cecilia, Farahani Ensieh, Synnerstad Ingrid, Fredrikson Mats, Enerbäck Charlotta, Rosdahl Inger, Söderkvist Pet |
| Amelanotic acral melanomas: clinicopathological, BRAF mutation, and KIT aberration analyses. Journal of the American Academy of Dermatology 2013 Nov 69 (5): 700-7. Choi Yoo Duk, Chun Seung Min, Jin Sun A, Lee Jee-Bum, Yun Sook Ju |
| KIR gene variability in cutaneous malignant melanoma: influence of KIR2D/HLA-C pairings on disease susceptibility and prognosis. Immunogenetics 2013 Jan . Campillo JA, Legaz I, López-Álvarez MR, Bolarín JM, Las Heras B, Muro M, Minguela A, Moya-Quiles MR, Blanco-García R, Martínez-Banaclocha H, García-Alonso AM, Alvarez-López MR, Martínez-Escribano JA |
| Melanoma risk is associated with vitamin D receptor gene polymorphisms. Melanoma research 2014 Jun 24 (3): 273-9. Zeljic Katarina, Kandolf-Sekulovic Lidija, Supic Gordana, Pejovic Janko, Novakovic Marijan, Mijuskovic Zeljko, Magic Zvon |
| Clinicopathological characteristics and mutation profiling in primary cutaneous melanoma. The American Journal of dermatopathology 2015 May 37 (5): 389-97. Yaman Banu, Akalin Taner, Kandilo?lu Gül? |
| Pathogenetic Implications of BRAF Mutation Distribution in Stage IV Melanoma Patients. Dermatology (Basel, Switzerland) 2015 231 (2): 127-33. Baiter Mirjam, Schuler Gerold, Hartmann Arndt, Schneider-Stock Regine, Heinzerling Luc |
| Genotyping and differential expression analysis of inflammasome genes in sporadic malignant melanoma reveal novel contribution of CARD8, IL1B and IL18 in melanoma susceptibility and progression. Cancer genetics 2016 Oct 209 (10): 474-480. da Silva Wanessa Cardoso, Oshiro Telma Miyuki, de Sá Daniel Coelho, Franco Dilcilea D G S, Festa Neto Cyro, Pontillo Alessand |
| Frequency of BRAF V600E Mutation in the Mexican Population of Patients With Metastatic Melanoma. Journal of global oncology 2018 Sep (4): 1-5. Ruiz-Garcia Erika, Matus-Santos Juan A, Guadarrama-Orozco Jorge Alberto, Alvarez-Avitia Miguel Angel, Aguilar-Ponce Jose Luis, Fernandez-Figueroa Edith, Maldonado-Mendoza Jessica, Lopez-Camarillo Cesar, Marchat Laurence A, Lino-Silva Saul, Cuellar-Hubbe Mario, de la Garza-Salazar Jamie, Meneses-García Abelardo, Astudillo-de la Vega Horacio, Martinez-Said Hect |
| Two synchronous malignancies: nodular melanoma and renal cell carcinoma in a patient with an underlying germline BRCA2 mutation. BMJ case reports 2019 6 12 (6): . Snow Anson, Ricker Charite, In Gino |
| BRAF, KIT, and NRAS Mutations of Acral Melanoma in White Patients. American journal of clinical pathology 2020 Feb . Dika Emi, Veronesi Giulia, Altimari Annalisa, Riefolo Mattia, Ravaioli Giulia Maria, Piraccini Bianca Maria, Lambertini Martina, Campione Elena, Gruppioni Elisa, Fiorentino Michelangelo, Melotti Barbara, Ferracin Manuela, Patrizi Annali |
| Low BRAF V600 mutation prevalence in primary skin nodular melanoma in Indonesia: a real-time PCR detection among Javanese patients. BMC proceedings 2019 13 (Suppl 11): 15. Rinonce Hanggoro Tri, Aji Rovi Panji Mustiko, Hayati Ni'mah, Pudjohartono Maria Fransiska, Kameswari Bidari, Irianiwat |
| Sensitivity and Usefulness of VE1 Immunohistochemical Staining in Acral Melanomas with BRAF Mutation. Annals of dermatology 2021 4 30 (5): 556-561. Suh Min Song, Choi Yoo Duk, Lee Jee-Bum, Lee Seung-Chul, Won Young Ho, Yun Sook Ju |
| PD-L1 expression is regulated by microphthalmia-associated transcription factor (MITF) in nodular melanoma. Pathology, research and practice 2021 12 229 153725. Vu?ini? Damir, Grahovac Maja, Grahovac Blaženka, Vitezi? Bojana Mohar, Kova? Leo, Beluši?-Gobi? Margita, Zamolo Gorda |
| Different Response to Immunotherapy According to Melanoma Histologic Subtype. Journal of immunotherapy (Hagerstown, Md. : 1997) 2021 12 45 (2): 119-124. Pala Laura, Conforti Fabio, Pagan Eleonora, Bagnardi Vincenzo, De Pas Tommaso M, Mazzarol Giovanni, Barberis Massimo, Pennacchioli Elisabetta, Orsolini Gianmarco, Prestianni Pierpaolo, Zagami Paola, Nicolo' Eleonora, Patanè Damiano, Saponara Maristella, Queirolo Pao |
| Associations between TERT Promoter Mutations and Survival in Superficial Spreading and Nodular Melanomas in a Large Prospective Patient Cohort. The Journal of investigative dermatology 2022 4 142 (10): 2733-2743.e9. Chang Gregory A, Robinson Eric, Wiggins Jennifer M, Zhang Yilong, Tadepalli Jyothirmayee S, Schafer Christine N, Darvishian Farbod, Berman Russell S, Shapiro Richard, Shao Yongzhao, Osman Iman, Polsky Dav |
| Assessing the genetic risk of nodular melanoma using a candidate gene approach. The British journal of dermatology 2023 9 . Mitchell S Stark, Richard A Sturm, Yan Pan, Darren J Smit, Varsha Kommajosyula, Katie J Lee, Kasturee Jagirdar, Catriona McLean, David L Duffy, H Peter Soyer, Victoria J M |
| Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma: a multicenter Dermatologic Cooperative Oncology Group study on 637 patients from the prospective skin cancer registry ADOREG. European journal of cancer (Oxford, England : 1990) 2023 5 188 140-151. Anne Zaremba, Peter Mohr, Ralf Gutzmer, Friedegund Meier, Claudia Pföhler, Michael Weichenthal, Patrick Terheyden, Andrea Forschner, Ulrike Leiter, Jens Ulrich, Jochen Utikal, Julia Welzel, Martin Kaatz, Christoffer Gebhardt, Rudolf Herbst, Anca Sindrilaru, Edgar Dippel, Michael Sachse, Frank Meiss, Lucie Heinzerling, Sebastian Haferkamp, Carsten Weishaupt, Harald Löffler, Sophia Kreft, Klaus Griewank, Elisabeth Livingstone, Dirk Schadendorf, Selma Ugurel, Lisa Zimm |
| BRAF and NRAS Mutations and the Association with Prognosis of Acral Lentiginous and Nodular Melanomas in Indonesia. Asian Pacific journal of cancer prevention : APJCP 2024 10 25 (10): 3525-3531. Sumadi Lukman Anwar, Paranita Ferronika, Roby Cahyono, William Sugandhi, Gizza Dandy Prada |
- Page last reviewed:Feb 1, 2024
- Content source: